undamentalytics Newsletter
Sign in

Methanex Corp (MEOH) stock

Add to watchlist

Add holding +

NASDAQ: MEOH Nasdaq Commodity Chemicals Next results ~January 27, 2027

B Fundamentals grade

Methanex Corp is a US-listed company in the commodity chemicals industry. Its financial year ends in December.

Stock price today

Loading chart…

Third-party market data · may be delayed

Fair value per share

~$81

Cash-flow model

Base case. Range ~$51–$120 across our lower- and higher-growth cases (-3%–7% a year).

Price vs value

Modestly undervalued

The price is inside our value range, 15% below our base value.

Price used: $68.45, November 2, 2026

Methanex Corp valuation: adjust assumptions and compare models →

Who’s trading

What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.

  • Funds126 adding, 103 cuttingOf 48 active managers that changed their stake, 27 added; quarter to June 30, 2026Fund buyers and sellers

Value diary

Our note on each quarter Methanex files

Where Methanex stands after its latest Filing

Revenue for the twelve months was $3.59bn, down 3.5% on a year earlier, a steeper fall than the 0.1% decline a quarter earlier. That puts it 11 of 13 for growth among the commodity chemicals companies we cover. Free-cash-flow margin rose to 25.5% from 20.2% a year earlier. Operating margin narrowed to 12.0% from 16.1%. The diluted share count is up 7.5% on a year earlier, which dilutes existing holders. Against its peers on growth, profitability, cash generation and balance sheet, it grades B. It passes 4 of our 6 financial-health checks. Our cash-flow model value is $80.83 a share, against a share price of $71.57. At that price, our model says the market is pricing in about 0.6% a year of cash-flow growth for five years, slower than the 6.3% a year revenue growth it has delivered.

Written from the company's filings and our models when each quarter's report arrives. Figures in older notes are as published at the time. Not investment advice.

The Fundamentalytics view

Next results ~January 27, 2027 (estimated)

Methanex Corp's trailing-twelve-month revenue fell 3.5% year on year, with a free-cash-flow margin of 25.5%. Where it stands out: gross margin of 35.7% ranks 1 of 13 commodity chemicals companies we cover. Where it lags: change in share count of 7.5% ranks 12 of 12 commodity chemicals companies we cover.

Our discounted-cash-flow model values the business at ~$81 per share in the base case (~$51–$120 across growth scenarios) — model values under stated assumptions, not a price target.

Current signal Free cash flow diverging from earnings: TTM free cash flow grew 44.1% while net income fell 42.1%: a 86pp divergence.

Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.

Highlights

How we pick these

Strengths

  • Strong cash generation. 25.5% of revenue turned into free cash flow, against a median of 2.9% for commodity chemicals companies we cover.
  • Estimates rising. Analysts' consensus for next year's earnings per share has risen 27.6% over 90 days.

Things to watch

  • Revenue shrinking. Revenue fell 3.5% over the last 12 months.
  • Share dilution. Diluted shares rose 7.5% in a year.
  • Growth easing. The growth rate is 3.4 points lower than a quarter earlier.
  • Below peers: change in growth rate. Change in growth rate of -3.4pp ranks 12 of 13 commodity chemicals companies we cover (median +3.6pp).
  • Missing expectations. Earnings per share fell short of the consensus estimate in 3 of the last four quarters.
  • Earnings expected to fall. The consensus expects earnings per share to fall 40% next year.

Latest results

Earnings per share
$3.69 against an average estimate of $2.86: beat by 29.2%
Next report
January 27, 2027; average EPS estimate $3.95

Methanex's figures from its SEC filings and results release; estimates are the analysts' average. Not a recommendation.

Price chart

  • 1 day-4.4%
  • 1 week+6.4%

Closing prices to 2026-11-02. Price change only, dividends excluded.

Loading chart…

Third-party market data · may be delayed

At a glance

Trailing twelve months, from SEC filings

Profitability

Revenue (TTM)
$3.6B
Operating margin
12.0%
Net margin
4.0%
EPS (TTM, diluted)
$1.99

Growth

Revenue growth
−3.5%
Change in growth rate
−3.4 pts
Share count change
+7.5%

Cash

Free cash flow (TTM)
$917M
FCF margin
25.5%
Stock pay % of revenue
-0.1%

News & updates

Updated November 2, 2026

Company announcements, filed results and changes that matter to shareholders.

No recent updates are available for MEOH from the sources we follow. See filings →

Refreshed hourly when new source data is available. Summaries are checked against company releases and SEC filings. Company announcement headlines are labelled when a checked summary is unavailable.

Valuation

Methanex Corp valuation models and calculator

What the price is pricing in

The share price implies cash flow shrinking about 0.1% a year for five years.That is slower than the 6.3% a year revenue growth Methanex has delivered.

  • Priced in-0.1%
  • Last 12 months-3.5%
  • 3 years a year-5.9%
  • 5 years a year6.3%

Our cash-flow model with every input fixed except growth over the next five years, solved for the growth at which the model value equals the share price ($67.28, Nov 3, 2026). Cash-flow growth then fades to 2.5% a year; discount rate 8.5%. Delivered figures are revenue growth from SEC filings. This is a model exercise, not investment advice or a forecast of the share price. All companies

Fundamentalytics rating

model v1.6 · 2026-11-03
Hold12-month view
12-month price target
~$81
Price used
$67.28close November 3, 2026
Implied change
▲ +20%
Uncertainty
High

How we got here: a discounted-cash-flow model of Methanex Corp's free cash flow after stock-based pay with after-tax interest added back ($511M, FY2025 Q4 TTM), growing 2% a year for five years and fading to 2.5%, discounted at 8.5%. Lower and higher growth cases span ~$51–~$120 ; that spread sets a 35% margin before we rate Buy or Sell.

Produced by Fundamentalytics' automated valuation model on November 3, 2026, using delayed market prices. Rating meanings, methodology and conflicts: recommendations disclosure and research disclaimer. General research, not personal advice — it does not consider your circumstances. Prices can fall as well as rise.

Our value per share comes from a discounted-cash-flow model of Methanex Corp's free cash flow after stock-based pay ( $511M, FY2025 Q4 TTM, with after-tax interest added back): growth for five years as below (the first two years from forecasts, guidance and the company's record), fading to 2.5%, discounted at 8.5%, then cash added and debt and other claims subtracted. These are model values under stated assumptions, not price targets or recommendations.

Valuation models

We value Methanex Corp as an operating company, with every model that fits that kind of business. Cost of equity 9.2%: the 10-year Treasury yield (4.9%) plus a beta of 0.94 times a 4.5% equity risk premium.

Value per share by model
Model Value per share In the combined value?
Cash-flow model (DCF) Free cash flow to the firm (after stock pay, with after-tax interest added back), grown then faded to 2.5%, discounted at 8.5% as the firm rate, less debt and other claims. ~$81 ~$51–$120 Primary model, counts double
Forward price-to-earnings vs peers Next year's consensus earnings per share times peers' typical (harmonic-mean) forward price-to-earnings. Uses analysts' consensus estimates (third-party data), not our forecasts. ~$99 ~$76–$190 Included
Residual income Book value plus the present value of returns above the cost of equity, fading over ten years. ~$100 ~$73–$150 Included
Justified price-to-book Book value times (return on equity - growth) / (cost of equity - growth): steady-state returns. ~$89 ~$77–$110 Included
Combined value Weighted average of the models that apply: the primary model (cash-flow model (dcf)) counts double. Models more than 5x or less than 0.2x the share price, or more than 3x away from the other models' median, are left out. ~$90 ~$81–$100 4 models

Different models fail in different ways, so where several apply we average them rather than trust one. Peer-based models compare Methanex Corp with Commodity Chemicals in our coverage, using third-party market data. Model values are estimates under stated assumptions, updated as new filings arrive; not price targets or investment advice. How each model works.

What moves the value

  • Revenue growth 5 points lower ▼ −30%
  • Revenue growth 5 points higher ▲ +40%
  • Free-cash-flow margin 1 point lower ▼ −4%
  • Last year's free-cash-flow margin change, if it persists ▲ +61%
  • Discount rate 1 point higher ▼ −17%
Value per share under different assumptions
Discount rate ↓ / growth → −5% growth0% growth5% growth10% growth15% growth20% growth
7% $66$102$150$213$296$403
8.5% $42$68$103$148$207$283
10% $27$48$74$109$154$212

Moat

Not assessed: fewer than five years of comparable figures in the filings. AI disruption exposure for this industry: Low.

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Forecasts and guidance

Next results: January 27, 2027, after the close. Analysts expect revenue of $1.4bn and EPS of $3.95 (range $2.94 to $4.37) for the quarter.

Analysts' consensus

Fiscal yearEPSGrowthRevenueGrowth
Current $11.86 +484% $5.2bn +46%
Next $7.09 −40% $4.2bn −19%

Next year's EPS estimate has moved +27.6% in 90 days, across 10 analysts.

How the EPS forecast has moved

The consensus EPS forecast for the current fiscal year is +30.8% on 90 days ago. In the last 30 days, 3 analysts raised Methanex Corp's forecast and 0 cut it.

Consensus EPS forecast Methanex Corp, last 90 days
$4.00 $6.00 $8.00 $10.00 $12.00 90 days ago 60 days ago 30 days ago 7 days ago Now Current fiscal year, 90 days ago: $9.07 Current fiscal year, 60 days ago: $9.02 Current fiscal year, 30 days ago: $9.11 Current fiscal year, 7 days ago: $9.84 Current fiscal year, Now: $11.86 $11.86 Next fiscal year, 90 days ago: $5.56 Next fiscal year, 60 days ago: $5.48 Next fiscal year, 30 days ago: $5.90 Next fiscal year, 7 days ago: $6.45 Next fiscal year, Now: $7.09 $7.09

Average of analysts' published estimates (third-party data).

View chart data
Period Current fiscal yearNext fiscal year
90 days ago $9.07$5.56
60 days ago $9.02$5.48
30 days ago $9.11$5.90
7 days ago $9.84$6.45
Now $11.86$7.09

Earnings against estimates

Quarter toEstimateActualSurprise
Sept 2026 $2.86 $3.69 +29.2%
Jun 2026 $4.01 $3.87 −3.5%
Mar 2026 $0.42 $0.30 −28.5%
Dec 2025 $0.65 −$0.14 −121.7%

Adjusted EPS as companies report it, against the average analyst estimate.

Analyst recommendations

10 analysts, Nov 2026
Buy770%
Hold330%
Sell00%

Monthly trend

  1. Nov 202625310
  2. Oct 202625310
  3. Sep 202625310
  4. Aug 202625310

Counts of recommendations published by analysts covering Methanex Corp, by month. Source: Aggregated broker recommendations (third-party data). Aggregated counts only: we do not reproduce any firm's recommendation or price target, and these are not Fundamentalytics ratings.

Positioning

Short interest
—
of tradable shares
Days to cover
3.05
at average volume
Short interest, 1 month
−9%
to October 15, 2026
Held by institutions
84%
of shares
Held by insiders
7.4%
of shares
Employees
1,649
full time

Consensus figures average analysts' published estimates (third-party data); guidance is the company's own. Neither is our forecast. Short interest is reported twice a month and lags. Market data may be delayed.

This section is general information, not investment advice or a personal recommendation, and it does not take account of your objectives or circumstances. Forecasts and guidance are estimates, not promises: companies miss their own guidance and analysts' figures are often revised. Prices can fall as well as rise, and you can lose money. See our disclaimer.

Share-price performance

Market data may be delayed

Recent prices are available. Older price history and the statistics that need it are being loaded in the background.

Price behaviour

52-week range
Not enough history
From 52-week high
—
vs 50-day average
—
vs 200-day average
—
Volatility (1 year)
—
Beta vs S&P 500
—

Volatility is the annualised standard deviation of daily returns. Beta 1.5 means the shares typically moved 1.5% for each 1% move in the S&P 500 over the past year. Prices to November 2, 2026.

Options strategies

All options ideas

How Methanex Corp’s listed options are priced, and three ways to use them that follow from our valuation. Quotes are delayed, read November 2, 2026. Check the live chain at your broker before trading.

Cash-secured put

Not offered: fundamentals grade B (needs B+ or better).

We suggest selling a put only on well-rated companies, at a strike where the price you would pay if assigned (strike less premium) is at or below our fair value.

Covered call

Not offered: no liquid call at or above our price target — the model says the upside is worth more than any listed strike.

For holders: sell a call at a strike at or above our fair value, so the shares are only sold at a price the model calls full value.

Collar

Not offered: the shares trade below our fair value: a collar caps upside the model expects.

For holders of a stock trading at or above our fair value: buy a put for a floor and sell a call to pay for it.

General research, not personal advice. Options can lose you more than you expect and are not suitable for everyone: put sellers can be made to buy shares that keep falling, call sellers give up gains above the strike, and results or news can move prices sharply. Chances shown are approximations from each option’s delta. Spreads, fees and early assignment are not modelled.

Methanex Corp in five measures

Fundamentals grade B
Growth Profitability Cash Balance sheet Value

Growth, profitability, cash generation and balance sheet are percentiles against the companies we cover in the same industry, from SEC filings (100 = best). Value compares the share price with our modelled value range (50 = at our base value; higher = cheaper). A description of reported data and our model — not a quality score or advice.

Fundamentals

Revenue (TTM) Methanex Corp
$1B $2B $3B $4B $5B FY16 Q4 FY18 Q4 FY20 Q4 FY22 Q4 FY25 Q4 Revenue (TTM), FY16 Q4: $2B Revenue (TTM), FY17 Q4: $3.1B Revenue (TTM), FY18 Q4: $4.5B Revenue (TTM), FY19 Q4: $3.3B Revenue (TTM), FY20 Q4: $2.6B Revenue (TTM), FY21 Q4: $4.4B Revenue (TTM), FY22 Q4: $4.3B Revenue (TTM), FY23 Q4: $3.7B Revenue (TTM), FY24 Q4: $3.7B Revenue (TTM), FY25 Q4: $3.6B $3.6B

Source: SEC EDGAR filings. Retrieved November 1, 2026.

View chart data
Period Revenue (TTM)
FY16 Q4 $2B
FY17 Q4 $3.1B
FY18 Q4 $4.5B
FY19 Q4 $3.3B
FY20 Q4 $2.6B
FY21 Q4 $4.4B
FY22 Q4 $4.3B
FY23 Q4 $3.7B
FY24 Q4 $3.7B
FY25 Q4 $3.6B
Revenue growth, TTM YoY Methanex Corp
-50% 0% 50% 100% FY17 Q4 FY19 Q4 FY21 Q4 FY23 Q4 FY25 Q4 Revenue growth, TTM YoY, FY17 Q4: 53.2% Revenue growth, TTM YoY, FY18 Q4: 46.5% Revenue growth, TTM YoY, FY19 Q4: -26.8% Revenue growth, TTM YoY, FY20 Q4: -19.3% Revenue growth, TTM YoY, FY21 Q4: 66.6% Revenue growth, TTM YoY, FY22 Q4: -2.3% Revenue growth, TTM YoY, FY23 Q4: -13.6% Revenue growth, TTM YoY, FY24 Q4: -0.1% Revenue growth, TTM YoY, FY25 Q4: -3.5% -3.5%

Source: SEC EDGAR filings. Retrieved November 1, 2026.

View chart data
Period Revenue growth, TTM YoY
FY17 Q4 53.2%
FY18 Q4 46.5%
FY19 Q4 -26.8%
FY20 Q4 -19.3%
FY21 Q4 66.6%
FY22 Q4 -2.3%
FY23 Q4 -13.6%
FY24 Q4 -0.1%
FY25 Q4 -3.5%
Operating margin (TTM) Methanex Corp
-10% 0% 10% 20% FY16 Q4 FY18 Q4 FY20 Q4 FY22 Q4 FY25 Q4 Operating margin (TTM), FY16 Q4: 1.4% Operating margin (TTM), FY17 Q4: 15.6% Operating margin (TTM), FY18 Q4: 18.5% Operating margin (TTM), FY19 Q4: 5.8% Operating margin (TTM), FY20 Q4: -2.0% Operating margin (TTM), FY21 Q4: 16.1% Operating margin (TTM), FY22 Q4: 14.2% Operating margin (TTM), FY23 Q4: 7.1% Operating margin (TTM), FY24 Q4: 9.7% Operating margin (TTM), FY25 Q4: 12.0% 12.0%

Source: SEC EDGAR filings. Retrieved November 1, 2026.

View chart data
Period Operating margin (TTM)
FY16 Q4 1.4%
FY17 Q4 15.6%
FY18 Q4 18.5%
FY19 Q4 5.8%
FY20 Q4 -2.0%
FY21 Q4 16.1%
FY22 Q4 14.2%
FY23 Q4 7.1%
FY24 Q4 9.7%
FY25 Q4 12.0%
FCF margin (TTM) Methanex Corp
0% 10% 20% 30% FY16 Q4 FY18 Q4 FY20 Q4 FY22 Q4 FY25 Q4 FCF margin (TTM), FY16 Q4: 6.3% FCF margin (TTM), FY17 Q4: 22.1% FCF margin (TTM), FY18 Q4: 17.6% FCF margin (TTM), FY19 Q4: 9.3% FCF margin (TTM), FY20 Q4: 12.5% FCF margin (TTM), FY21 Q4: 20.2% FCF margin (TTM), FY22 Q4: 19.5% FCF margin (TTM), FY23 Q4: 12.9% FCF margin (TTM), FY24 Q4: 17.1% FCF margin (TTM), FY25 Q4: 25.5% 25.5%

Source: SEC EDGAR filings. Retrieved November 1, 2026.

View chart data
Period FCF margin (TTM)
FY16 Q4 6.3%
FY17 Q4 22.1%
FY18 Q4 17.6%
FY19 Q4 9.3%
FY20 Q4 12.5%
FY21 Q4 20.2%
FY22 Q4 19.5%
FY23 Q4 12.9%
FY24 Q4 17.1%
FY25 Q4 25.5%

Data: SEC EDGAR XBRL company facts (as filed in 10-K/10-Q); forms 40-F. Generated November 3, 2026. Definitions in our methodology.

Where the money goes

FY2025, from the 10-K

Each dollar Methanex took in during FY2025, followed through to profit: what it cost to make, what went on running the business, and what was left after tax.

  1. Revenue $3.6B
  2. Cost of revenue $2.3B · 64.3%
  3. Gross profit $1.3B · 35.7%
  4. Selling, general and admin $117M · 3.3%
  5. Other operating costs $733M · 20.4%
  6. Operating income $431M · 12.0%
  7. Income tax $58.4M · 1.6%
  8. Interest and other $228M · 6.3%
  9. Net income $145M · 4.0%

Shares of revenue. Source: Methanex's 10-K for FY2025, as filed with the SEC. "Other" lines are what the reported lines leave unexplained.

Financial statements

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year 2016 Dec 2016 2017 Dec 2017 2018 Dec 2018 2019 Dec 2019 2020 Dec 2020 2021 Dec 2021 2022 Dec 2022 2023 Dec 2023 2024 Dec 2024 2025 Dec 2025
Income
Revenue 1,998 3,061 4,483 3,284 2,650 4,415 4,311 3,723 3,720 3,589
Gross profit 465 1,025 1,354 713 542 1,303 1,073 926 1,042 1,281
EBITDA 257 709 1,075 534 305 1,075 983 655 748 877
Operating income 28 476 830 189 −52 712 611 264 362 431
Net income −28 375 658 116 −125 556 462 284 250 145
Diluted EPS −$0.14 $3.64 $6.92 $1.01 −$2.06 $6.13 $4.86 $2.57 $2.39 $0.93
Growth (year on year)
Revenue — +53.2% +46.5% −26.8% −19.3% +66.6% −2.3% −13.6% −0.1% −3.5%
EBITDA — +176.3% +51.7% −50.4% −42.9% +252.8% −8.6% −33.3% +14.1% +17.3%
Operating income — — +74.1% −77.2% −127.7% — −14.2% −56.8% +37.3% +19.1%
Net income — — +75.4% −82.3% −207.7% — −16.8% −38.5% −11.9% −42.1%
Diluted EPS — — +90.1% −85.4% −304.0% — −20.7% −47.1% −7.0% −61.1%
Margins
Gross margin 23.2% 33.5% 30.2% 21.7% 20.5% 29.5% 24.9% 24.9% 28.0% 35.7%
EBITDA margin 12.8% 23.2% 24.0% 16.3% 11.5% 24.4% 22.8% 17.6% 20.1% 24.4%
Operating margin 1.4% 15.6% 18.5% 5.8% −2.0% 16.1% 14.2% 7.1% 9.7% 12.0%
Net margin −1.4% 12.3% 14.7% 3.5% −4.7% 12.6% 10.7% 7.6% 6.7% 4.0%
Free-cash-flow margin 6.3% 22.1% 17.6% 9.3% 12.5% 20.2% 19.5% 12.9% 17.1% 25.5%
Cash flow
Cash from operations 227 780 980 515 461 994 987 660 737 1,016
Capital spending 100 103 191 208 129 103 146 178 101 99
Free cash flow 127 677 790 307 332 891 842 482 636 917
Stock-based pay 33 79 −6 −4 55 −1 15 35 24 −4
Free cash flow after stock pay 93 598 796 311 277 892 826 447 612 921
Balance sheet
Cash 224 375 256 417 834 932 858 458 892 425
Total debt 1,556 1,502 1,458 1,769 2,363 2,158 2,152 2,142 2,415 2,753
Net debt (negative = net cash) 1,332 1,127 1,202 1,352 1,530 1,226 1,294 1,684 1,523 2,328
Diluted shares 90m 87m 81m 77m 76m 76m 72m 68m 68m 73m
Returned to shareholders
Dividends 99 101 106 108 36 25 44 49 50 54
Buybacks 0 286 444 53 0 63 253 86 0 —
Total returned 99 388 550 161 36 88 297 136 50 54

Source: SEC EDGAR XBRL company facts (US and foreign periodic filings); column headings link to the filing. EBITDA is operating income plus depreciation and amortisation. Free cash flow is cash from operations minus capital spending. Growth is left blank when last year's figure was a loss or under 2% of revenue. Share counts and EPS are restated for stock splits. A dash means the company didn't report the figure.

Financial health

4 of 6 checks passed · December 31, 2025
What it owns · $7.3bn
Short-term assets $1.5bnLonger-term assets $5.8bn
What it owes, and who funded it · $3.2bn
Short-term liabilities $722mShareholders' equity $2.4bn
  • Short-term assets cover short-term liabilities $1.5bn of assets due within a year against $722m of liabilities due within a year.
  • Short-term assets cover long-term liabilities Not assessable from the reported split. Not assessable.
  • More cash than debt $425m of cash against $2.8bn of debt.
  • Debt below 40% of shareholders' equity Debt is 113% of equity.
  • Debt burden no higher than five years ago Debt to equity moved from 202% to 113% over five years.
  • A year's operating cash flow covers at least 20% of debt $1.0bn of operating cash flow against $2.8bn of debt.
  • Operating profit covers interest at least five times over Operating income of $431m against $50m of interest.

From Methanex Corp's latest balance sheet as filed. Checks are fixed, documented rules (methodology), counted only where the company reports the figures — a dot means the filing doesn't break the item out. Descriptions of reported data, not advice.

Dividends, buybacks and capital spending

FY2024 Q4 TTM
Buybacks (TTM)
$0
Dividends (TTM)
$53.6M
Returned to shareholders
8%
of free cash flow
Buybacks, last 3 fiscal years
$339M
Diluted share count
+7.5%
year over year
Total shareholder yield
1.1%
dividends 1.1% + buybacks 0.0% of market value
Dividend payout ratio
37%
of net income paid out
Days sales outstanding
47 days
receivables vs revenue

Competitors: side by side with peers

Closest by revenue in commodity chemicals
Last 12 months unless stated MEOH TROX CC VHI KRO OLN Median
Revenue, last 12 months $3.6bn $3.1bn $5.8bn $2.2bn $1.9bn $6.7bn $2.2bn
Revenue growth, last 12 months −3.5% 3.7% −0.9% 3.4% 2.7% −0.7% −0.7%
Revenue growth, 3-year average — 0.1% −2.9% 3.4% 5.1% −2.2% −2.4%
Revenue growth, latest quarter — 18.7% −1.5% 12.2% 12.9% 2.0% 9.0%
Gross margin 35.7% 6.2% 15.3% 14.7% 11.8% 6.7% 11.8%
Operating margin 12.0% −7.2% — 3.6% −1.7% −1.9% −1.8%
Operating margin, 3-year average 14.6% −0.5% — 6.3% 1.9% 2.2% 3.2%
Net margin 4.0% −18.0% −5.2% −2.4% −5.6% −3.3% −4.6%
Cash from operations / revenue 28.3% 3.3% 6.8% 5.2% 4.4% 5.8% 5.8%
Free-cash-flow margin 25.5% −5.2% 3.8% 2.9% 1.2% 3.3% 2.9%
Free-cash-flow margin, 3-year average 22.6% −4.6% −3.0% 0.0% 0.6% 4.4% 0.6%
Stock pay / revenue −0.1% 0.7% 0.4% — — 0.4% 0.4%
Change in share count 7.5% 0.7% 0.4% 0.0% 0.0% −2.4% 0.0%

Median of all 13 companies we cover in commodity chemicals. Shaded: best of the six on that line (lowest for stock pay and share-count growth). 3-year figures average the last three 12-month periods; 3-year growth is compound annual. Source: SEC filings.

Peer comparison

13 commodity chemicals companies
Measure Company Peer median Rank
Revenue growth Growth -3.5% -0.7% 11 of 13
Change in growth rate Growth -3.4pp +3.6pp 12 of 13
Gross margin Profitability 35.7% 11.8% 1 of 13
Operating margin Profitability 12.0% -1.7% 1 of 10
Net margin Profitability 4.0% -4.6% 2 of 13
Free-cash-flow margin Cash generation 25.5% 2.9% 1 of 13
Stock pay as % of revenue Cash generation -0.1% 0.4% 1 of 10
Long-term debt as % of assets Balance sheet 37.2% 37.2% 7 of 12
Change in share count Balance sheet 7.5% 0.4% 12 of 12
Days sales outstanding Balance sheet 47 days 47 days 5 of 9

Rank 1 = best in the group (for spending, debt and dilution, lower ranks first).

Who owns it

Funds buying and selling
Reported value
$2.8B
Institutions reporting
210
Shares held vs prior quarter
▲ 8.4%
Positions opened / closed
44 / 45

Top buyers and sellers, Q2 2026: 126 institutions bought and 103 sold ; the biggest buyer was Boston Partners (+1.4M shares) and the biggest seller FMR LLC (−1.6M). See which funds bought and sold →

Largest reported holders, June 30, 2026
Manager Value Shares Share of 13F value Shares QoQ
M&G PLC $568M 12.3M 20.5% ▼ 0.9%
Boston Partners $193M 4.2M 7.0% ▲ 52.8%
Wellington Management Group LLP $183M 4.0M 6.6% ▼ 11.9%
Mackenzie Financial Corp $125M 1.9M 4.5% ▲ 15.7%
Vanguard Capital Management LLC $97.5M 2.1M 3.5% ▲ 8.8%
Dixon Mitchell Investment Counsel Inc. $88.5M 1.9M 3.2% ▼ 1.7%
Fil Ltd $88.4M 1.9M 3.2% ▼ 43.8%
Millennium Management LLC $72M 1.6M 2.6% ▲ 127.5%
Bank Of Montreal $60.5M 1.3M 2.2% ▼ 3.6%
Royal Bank Of Canada $60.4M 1.3M 2.2% ▲ 25.5%
Bank Of America Corp $56.7M 1.2M 2.0% ▲ 80.2%
Connor, Clark & Lunn Investment Management Ltd. $53.6M 1.2M 1.9% ▼ 34.7%

From Form 13F filings with the SEC ( quarterly data sets), as reported by each manager for June 30, 2026 and filed up to 45 days later. 13F reports cover long US-listed positions of managers above $100M only, so this is not Methanex Corp's complete shareholder register. Values are as reported by the filers .

Insider trading activity

Full insider history and chart
Insider purchases History → $0 0 trades by 0 insiders, last 12 months Insider sales History → $0 0 trades by 0 insiders
Net ▲ $0 net buying

No open-market insider trades reported in the last 12 months.

From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.

Trades by members of Congress

All 2 trades and filings

No trades in Methanex Corp disclosed in the last 12 months; 2 earlier trades on record.

  • Earl Blumenauer(D-OR 3):Sale (full), $1,001 - $15,000, traded March 10, 2020, filed April 16, 2020
  • Earl Blumenauer(D-OR 3):Purchase, $1,001 - $15,000, traded May 9, 2019, filed June 4, 2019

Value ranges as filed; reports can arrive up to 45 days after a trade.

Earnings dates and SEC filings

Results announcements

Recent SEC filings

Data status

When each part of this page on Methanex Corp was last updated.

DataLast updatedSource
Share priceExchange closing prices
News and updatesCompany releases and SEC 8-K filings
Analyst estimatesAggregated analyst estimates
Valuation and scoresOur models, from the filed figures

How we build and check these figures: methodology and data sources.

Methanex Corp in brief

What does Methanex Corp do?
Methanex Corp is a US-listed company in the commodity chemicals industry. Its financial year ends in December.
What is Methanex Corp's stock ticker?
Methanex Corp trades under the ticker MEOH on Nasdaq. This page brings together its financial statements, valuation models, ownership and recent company updates.
What is Methanex Corp's revenue, and how fast is it growing?
Over its most recent trailing twelve months, Methanex Corp reported revenue of $3.6B, 3.5% lower than a year earlier, according to its SEC filings.
What is Methanex Corp's free cash flow?
Methanex Corp's free-cash-flow margin is 25.5% of revenue over the trailing twelve months, ranking 1 of the 13 commodity chemicals companies we cover.
What is Methanex Corp's fair value (intrinsic value) per share?
Our discounted-cash-flow model of Methanex Corp's free cash flow after stock-based pay gives ~$81 per share in the base case, and ~$51–$120 across growth scenarios. These are model values under stated assumptions — not a price target or a recommendation.
Who are Methanex Corp's largest institutional shareholders?
By value reported in 13F filings for June 30, 2026, the largest reported holders are M&G PLC, Boston Partners and Wellington Management Group LLP. 13F reports cover long US-listed positions of managers above $100M, filed up to 45 days after quarter end.
Is Methanex Corp buying back stock, and does it pay a dividend?
Methanex Corp spent $0 on share repurchases over the trailing twelve months, and its diluted share count still rose 7.5% over the year.
Does Methanex Corp pay a dividend?
Yes: Methanex Corp paid $53.6M in dividends over the trailing twelve months, a dividend yield of 1.08% and a payout ratio of 37.0%.
How much debt does Methanex Corp have?
Methanex Corp's debt-to-equity ratio is 112.7%, from its latest balance sheet (202.2% five years earlier). The financial health section below sets out its other solvency checks.
Who are Methanex Corp's competitors?
In our Commodity Chemicals peer group, the companies closest to Methanex Corp are Tronox Holdings plc, Chemours Co, Valhi Inc, Kronos Worldwide Inc and Olin Corp. The side-by-side comparison below sets their revenue, margins and growth against Methanex Corp's.
When is Methanex Corp's next earnings date?
Around January 27, 2027, estimated from the spacing of its past results announcements (8-K filings). That is an estimate, not a confirmed date — Methanex Corp announces its own schedule.